No Data
No Data
Eight Stocks Positioned for Short Sales – Oppenheimer Asset Management
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
Exelixis And Merck Sign Clinical Development Collaboration To Evaluate Investigational Zanzalintinib In Combination With KEYTRUDA In Head And Neck Cancer And In Combination With WELIREG In Renal Cell Carcinoma
Express News | Exelixis Inc - Retains Global Commercial Rights to Zanzalintinib
Express News | Exelixis Inc - Merck to Supply Keytruda for Phase 3 Stellar-305 Trial
Express News | Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination With Keytruda® (Pembrolizumab) in Head and Neck Cancer and in Combination With Welireg® (Belzutifan) in Renal Cell Carcinoma
loading...
No Data
No Data